priv.jpg
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
24 janv. 2025 09h00 HE | Privia Health Group, Inc.
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
priv.jpg
Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program
29 oct. 2024 17h04 HE | Privia Health Group, Inc.
Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program; $176.6M in Shared Savings Delivered Across 10 Participating ACOs
cmi_logo.png
[Latest] Global Luxury Jewelry Market Size/Share Worth USD 97.8 Billion by 2032 at a 8.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
16 nov. 2023 14h30 HE | Custom Market Insights
Austin, TX, USA, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Luxury Jewelry Market Size, Trends and Insights By Product Type (Diamond...
cmi_logo.png
[Latest Report] Global Pearl Jewelry Market Size/Share Worth USD 24.37 Billion by 2030 at a 12.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
08 mai 2023 07h30 HE | Custom Market Insights
Austin,TX, USA, May 08, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pearl Jewelry Market Size, Trends and Insights By Pearl Type Insights (Freshwater,...
CO-MasterLogo@4x_300 DPI.png
Cullinan Oncology Announces Updated Phase 1/2a Data for CLN-081 in NSCLC EGFR Exon 20 Patients
16 déc. 2021 06h30 HE | Cullinan Oncology, Inc.
CLN-081 continues to demonstrate a differentiated clinical profile at the recommended Phase 2 dose of 100mg BID Continued high response rate with favorable safety and tolerability profile observed in...
CO-MasterLogo@4x_300 DPI.png
Cullinan Oncology to Provide Clinical Update for CLN-081 in NSCLC EGFR Exon 20 Patients
13 déc. 2021 07h00 HE | Cullinan Oncology, Inc.
CAMBRIDGE, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology therapies,...
gmi 2018.png
World Millets Market value to surpass $12 billion by 2025: Global Market Insights, Inc.
10 juin 2019 06h00 HE | Global Market Insights, Inc
Selbyville, Delaware, June 10, 2019 (GLOBE NEWSWIRE) -- The Millets market is highly fragmented and has been witnessing participation from various producers and processors. FPOs and organic...
iambic Announces Availability of Health & Diet Manager for BlackBerry
26 mars 2009 13h05 HE | iambic, Inc.
SAN JOSE, CA--(Marketwire - March 26, 2009) - iambic, Inc., a leading provider of innovative productivity-enhancing software, today announced the availability of Health & Diet Manager for...